Development of modified siRNA molecules incorporating 5-fluoro-2'-deoxyuridine residues to enhance cytotoxicity
Authors:
- Tian-Min ChenTCTian-Min Chen
- William H. GmeinerWGWilliam H. Gmeiner
- Edward ChuECEdward Chu
- John C. SchmitzJSJohn C. Schmitz
Open Access
- 28 February 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 41 (8) , 4650-4659
Abstract
Therapeutic small interfering RNAs (siRNAs) are composed of chemically modified nucleotides, which enhance RNA stability and increase affinity in Watson–Crick base pairing. However, the precise fate of such modified nucleotides once the siRNA is degraded within the cell is unknown. Previously, we demonstrated that deoxythymidine release from degraded siRNAs reversed the cytotoxicity of thymidylate synthase (TS)-targeted siRNAs and other TS inhibitor compounds. We hypothesized that siRNAs could be designed with specific nucleoside analogues that, once released, would enhance siRNA cytotoxicity. TS-targeted siRNAs were designed that contained 5-fluoro-2′-deoxyuridine (FdU) moieties at various locations within the siRNA. After transfection, these siRNAs suppressed TS protein and messenger RNA expression with different efficiencies depending on the location of the FdU modification. FdU was rapidly released from the siRNA as evidenced by formation of the covalent inhibitory ternary complex formed between TS protein and the FdU metabolite, FdUMP. These modified siRNAs exhibited 10–100-fold greater cytotoxicity and induced multiple DNA damage repair and apoptotic pathways when compared with control siRNAs. The strategy of designing siRNA molecules that incorporate cytotoxic nucleosides represents a potentially novel drug development approach for the treatment of cancer and other human diseases.Keywords
This publication has 32 references indexed in Scilit:
- RNA-Based Therapeutics: Current Progress and Future ProspectsChemistry & Biology, 2012
- Cellular pharmacology of multi- and duplex drugsconsisting of ethynylcytidine and 5-fluoro-2′-deoxyuridineInvestigational New Drugs, 2009
- Sticky overhangs enhance siRNA-mediated gene silencingProceedings of the National Academy of Sciences, 2007
- Position-specific chemical modification of siRNAs reduces “off-target” transcript silencingRNA, 2006
- Design of Noninflammatory Synthetic siRNA Mediating Potent Gene Silencing in VivoMolecular Therapy, 2006
- Small Interfering Double-Stranded RNAs as Therapeutic Molecules to Restore Chemosensitivity to Thymidylate Synthase Inhibitor CompoundsCancer Research, 2004
- Mechanisms of apoptosis induction by nucleoside analogsOncogene, 2003
- Thymineless death in colon carcinoma cells is mediated via Fas signalingProceedings of the National Academy of Sciences, 1997
- Cytotoxicity of antifolate inhibitors of thymidylate and purine synthesis to WiDr colonic carcinoma cells.1993
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970